Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Laboratory Medicine|November 3, 2017
Opioid Use Disorders, Medication-Assisted Treatment, and the Role of the LaboratoryRoger L Bertholf, Gary M ReisfieldJournal of Analytical Toxicology|August 24, 2016
Predictive Value of Positive Drug Screening Results in an Urban Outpatient PopulationRoger L Bertholf, Rohit Sharma, Gary M ReisfieldAnnals of Clinical and Laboratory Science|November 15, 2007
Rational use and interpretation of urine drug testing in chronic opioid therapyGary M Reisfield, Elaine Salazar, Roger L BertholfJournal of Analytical Toxicology|October 8, 2014
Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold resultsRoger L Bertholf, Laura M Johannsen, Gary M ReisfieldJournal of Opioid Management|March 10, 2015
Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain managementGary M Reisfield, Bruce A Goldberger, Roger L BertholfBioanalysis|November 19, 2010
'False-positive' and 'false-negative' test results in clinical urine drug testingGary M Reisfield, Bruce A Goldberger, Roger L BertholfJournal of Opioid Management|February 23, 2008
Family physicians' proficiency in urine drug test interpretationGary M Reisfield, Fern J Webb, Roger L Bertholf, et al.Journal of Analytical Toxicology|May 31, 2011
Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwashGary M Reisfield, Bruce A Goldberger, Amadeo J Pesce, et al.Journal of Analytical Toxicology|March 15, 2011
Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to an ethanol-based hand sanitizerGary M Reisfield, Bruce A Goldberger, Bridgit O Crews, et al.Journal of Pain & Palliative Care Pharmacotherapy|December 8, 2010
Medical cannabis and chronic opioid therapyGary M ReisfieldPageof 6